Verinata's Fetal Test Patent Survives AIA Review On All Claims
The Patent Trial and Appeal Board ruled Thursday that Ariosa Diagnostics Inc. hadn't shown that Verinata Health Inc.'s "fetal abnormality" detection patent was invalid due to obviousness, marking a rare instance...To view the full article, register now.
Already a subscriber? Click here to view full article